Journal of Pharmaceutical Policy and Practice

Cancer Pain Management is a critical aspect of comprehensive cancer care. The role of pharmacists in ensuring effective pain associated with cancer and its treatments should not be underestimated. Pharmacists have the expertise to optimize pain management regimens, mitigate side effects, and enhance patients' pharmacists overall quality of life during their cancer journey.

In this article collection, the multifaceted role of pharmacists in cancer pain management is explored, emphasizing pharmacist’s involvement is indispensable. Pharmacists can function as a bridge between healthcare providers and patients, offering personalized pain relief strategies, ensuring medication safety, and promoting adherence to treatment plans. Their interventions not only help to alleviate physical suffering but also address emotional and psychological distress that often accompanies cancer pain.

Subtopics covered in this collection may include (but are not limited to):
• Pharmacists' Expertise: Delve into the specialized knowledge and skills that pharmacists can offer when managing cancer pain.
• Multidisciplinary Collaboration: Highlight the importance of pharmacists collaborating with oncologists, nurses, and other healthcare professionals to provide holistic pain management.
• Patient-Centred Care: Explore patient-centric approaches that pharmacists employ to tailor pain management strategies to individual’s needs and preferences.
• Pharmacotherapy: Discuss the latest advancements in cancer pain medications and the pharmacist's role in selecting, dosing, and monitoring their effectiveness.
• Education and Counselling: Examine how pharmacists educate patients and caregivers about pain management, potential side effects, and self-care techniques.

We invite submissions of various article types, including research papers, reviews, case studies, and opinion pieces, which contribute to our understanding of the vital role played by pharmacists in cancer pain management. Authors can share insights, best practices, and innovative approaches that can ultimately improve the quality of life for cancer patients, making their journey more bearable and hopeful.

 

---

Professor Siew Hua Gan obtained her undergraduate degree in pharmacy from Manchester University, England and subsequent higher qualifications (M. Pharm and PhD) from Universiti Sains Malaysia (USM).

Gan serves on the editorial board of several journals such as Seminars in Cancer Biology, Frontiers in Pharmacology, PlosOne journal, International Journal of Hypertension, Current Chemical Genomics & Translational Medicine, World Journal of Medical Genetics and Evidence-Based Complementary Alternative Medicine.

 

Sunil Shrestha is a registered pharmacist and clinical researcher from Nepal, pursuing a PhD at the School of Pharmacy Monash University. He is currently doing a PhD in cancer pain management. He has amassed valuable experience working as a Clinical Pharmacist and Research Associate at a leading cancer hospital in Nepal. He is also on the editorial board of BMC Health Services Research and PloS One.

 

Dr. Simit Sapkota is the leading Oncologist in the country, Nepal, and is a vocal advocate of "Quality treatment to all". He is an alumnus of the prestigious Post Graduate Institute (PGI -Chandigarh) He is involved in the management of all kinds of malignancies and has a special interest in GI-HPB cancers, Gynaecological cancers, and pain and palliative care in cancer patients. He also has a special interest in immunotherapy and targeted therapy in gastrointestinal/ pancreatic and hepato-biliary cancers. His research interest includes opioid usage and palliative care management especially in LMICs.

Prof. Siew Hua Gan, Sunil Shrestha and Dr. Simit Sapkota declare no conflict of interest.

Instructions for AuthorsSubmit an Article